There has been a significant increase in pharma shipments to the U.S. as businesses prepare for potential tariffs under threat from Trump. The U.S. trade deficit widened to a record $140.5 billion as companies and consumers attempt to stay ahead of these tariffs. Pharma imports surged in March as drugmakers aim to avoid the impending tariffs. The cost of Trump’s trade policies is becoming increasingly evident.
— new from Axios